Description
Cartalax (AED) — Research Use Only
Overview
A synthetic three-amino-acid peptide (tripeptide), supplied as a laboratory reagent.
Chemical Identification
| Sequence | Ala-Glu-Asp |
| Molecular formula | C12H19N3O8 |
| Molecular weight | 333.3 g/mol |
| PubChem CID | 87815447 |
| Purity | 99.927% July 2026 |
| Storage | -20°C |
Research Areas
- A synthetic tripeptide (Ala-Glu-Asp) from the Khavinson peptide series, corresponding to a sequence found in the alpha-1 chain of type XI collagen.
- Studies have examined its interaction with chondrocyte gene regulatory regions and expression of genes for type II collagen and proteoglycans.
- Human fibroblast cultures have been used to examine caspase-dependent apoptosis and MMP-9 synthesis in young and aged cells.
- Research has examined short-peptide effects on gene expression in mesenchymal stem cell cultures during ageing.
- A 2019 study in aged rats (Advances in Gerontology) examined Khavinson-series peptides, including Cartalax, in kidney tissue.
Handling and Storage
Supplied as a lyophilised powder in a sealed vial. Store as stated above, protected from light and moisture, and avoid repeated freeze-thaw cycles. Any reconstitution must take place in a controlled laboratory setting.
Certificate of Analysis
Purity is specified per batch. The independent third-party batch report for this product is available on request. Email Contact@huntresearchlabs.com with the product name and your order number.
Regulatory Note
This product is not a licensed medicine and has not been evaluated by the MHRA, FDA or any other regulator for any use. It is supplied for in vitro laboratory research only.
Research Use Disclaimer: This product is intended exclusively for laboratory research and in vitro use by qualified researchers. It is not for human or veterinary consumption, diagnostic use, or therapeutic application. See our full Terms and Conditions of Research Use for complete usage terms.






Reviews
There are no reviews yet.